Kamada Ltd
NASDAQ:KMDA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.78
6.42
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Kamada Ltd
Total Assets
Kamada Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Kamada Ltd
NASDAQ:KMDA
|
Total Assets
$351.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
||
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Assets
$34.1m
|
CAGR 3-Years
47%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
||
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Assets
$301.9m
|
CAGR 3-Years
31%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
||
Entera Bio Ltd
NASDAQ:ENTX
|
Total Assets
$7.7m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
||
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Assets
â‚Ş32m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
Pluri Inc
NASDAQ:PLUR
|
Total Assets
$35.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-6%
|
Kamada Ltd
Glance View
Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
See Also
What is Kamada Ltd's Total Assets?
Total Assets
351.2m
USD
Based on the financial report for Sep 30, 2024, Kamada Ltd's Total Assets amounts to 351.2m USD.
What is Kamada Ltd's Total Assets growth rate?
Total Assets CAGR 10Y
11%
Over the last year, the Total Assets growth was 4%. The average annual Total Assets growth rates for Kamada Ltd have been 17% over the past three years , 18% over the past five years , and 11% over the past ten years .